Testing effectiveness (Phase 2)Looking for participantsNCT07135050
What this trial is testing
Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
Who this might be right for
Pitt Hopkins Syndrome
Mahzi Therapeutics 12